Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Flow Cytomteric Detection of Minimal Residual Disease

Flow Cytomteric Detection of Minimal Residual Disease

Kandeel, Eman
Kamel, Azza

Paperback

Medical Reference

ISBN10: 3659405760
ISBN13: 9783659405761
Publisher: Lap Lambert Academic Pub
Published: Jun 19 2013
Pages: 144
Weight: 0.49
Height: 0.34 Width: 6.00 Depth: 9.00
Language: English
A crucial problem for oncologist in treatment of acute leukemia is the characterization of patients who require more intensification of therapy to avert relapse. Although clinical (e.g., age, gender) and biologic (e.g., white blood cell count, immunophenotype, structural chromosomal abnormalities, and gene rearrangements) factors can be used for treatment stratification, none of these prognostic parameters is optimal. A proportion of patients with low risk experiences relapse, while others may receive more aggressive treatment than is necessary. Studies of minimal residual disease (MRD) focus at improving the estimation of leukemic burden during treatment. This information provides an indicator of the aggressiveness and drug sensitivity of the disease and guide in the selection of appropriate therapeutic strategies.

Also in

Medical Reference

View All